MB-10866

N/A

Report date: 2022/01/25 16:47:40
NME

Base Information

Drug NameMB-10866
Drug Alias NameMB-10866VK-0214
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionThyroid hormone receptor beta-1 agonists
TargetsThyroid hormone receptor beta
Therapy Area/IndicationsAdrenoleukodystrophy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesMetabasis Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesViking Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsAdrenoleukodystrophy
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A